Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Castle Biosciences, Inc.

Castle Biosciences, Inc. (CSTL) Stock Overview

Explore Castle Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CSTL●NASDAQ
HealthcareMedical - Diagnostics & Research
$24.51
$1.39(6.003%)
U.S. Market is Open · 15:18

Castle Biosciences, Inc. (CSTL)

Meyka AI Score

Z

Key Financials

Market Cap728.5M
P/E Ratio-55.81
EPS (TTM)$-0.44
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$20.56
3 Months$31.04
1 Year Target$32.53

CSTL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Castle Biosciences, Inc. (CSTL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -55.81 and a market capitalization of 728.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.89%
5-Day Change
-2.16%
1-Month Change
16.26%
3-Month Change
-2.44%
6-Month Change
-41.06%
Year-to-Date (YTD) Change
-38.25%
1-Year Change
27.29%
3-Year Change
45.58%
5-Year Change
-63.01%
All-Time (Max) Change
12.24%

Contact Information

https://castlebiosciences.com
866 788 9007
505 South Friendswood Drive, Friendswood, TX, 77546

Company Facts

9,420 Employees
IPO DateJul 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions